We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Dezima In-Licenses CETP Inhibitor Program from MTPC

News   Apr 25, 2013

 
Dezima In-Licenses CETP Inhibitor Program from MTPC
 
 
 

RELATED ARTICLES

Protein Gives Identical Cells Individuality

News

New insight into a protein's role in regulating tight DNA packing could have implications for combating tumor cell resistance to anti-cancer treatments.

READ MORE

Marathon-running Molecule Set to Accelerate the Race for Novel Neurological Drugs

News

Two proteins that activate the fastest molecule in our nerve cells have been identified by researchers at University of Warwick. This mechanism is responsible for transport through our nervous system. This finding could lead to a new therapeutic treatments for people with hereditary spastic paraplegia and other neurological disorders.

READ MORE

Larger, Earlier Drug Trials Needed to Fight Alzheimer's

News

There are currently no drugs that stop or inhibit Alzheimer's disease. Despite drug trials showing plaque reduction in the brain, the patients' cognitive function did not improve. Would the results be different if it were possible to design studies that intervene much earlier on in the disease, before cognition is affected?

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE